Natco Pharma posts Rs 715.3 crore of Profit after tax for year ended March 31st, 2023 Ruchika Sharma30 May 2023 8:00 AM GMTThe profit for the fourth quarter, on a consolidated basis was INR 275.8 Crore, as against a loss of INR 50.5 Crore last year fourth quarter.
Natco Pharma to set up subsidiary in Indonesia with investment of Rs 25 crore Ruchika Sharma21 April 2023 5:45 AM GMTNatco will initially invest USD 1 million for a stake of 51 per cent as capital contribution and balance will be invested as and when the funds are...
Natco Pharma rolls out additional strengths for generic version of Revlimid in US Ruchika Sharma10 March 2023 8:45 AM GMTLenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada Ruchika Sharma1 March 2023 6:45 AM GMTMultiple myeloma, commonly referred to as myeloma, is a cancer of plasma cells.
Natco Pharma announces submission of ANDA with USFDA for generic version of Olaparib Tablets Ruchika Sharma13 Feb 2023 6:55 AM GMTOlaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer.
Natco Pharma consolidated net profit declines 22 percent at Rs 62 crore in Q3 Ruchika Sharma10 Feb 2023 10:00 AM GMTNew Delhi: Natco Pharma has announced that its consolidated net profit declined by 22 percent to Rs 62 crore for the third quarter ended December 31,...
Natco Pharma gets 2 observations from USFDA for Vizag facility Ruchika Sharma5 Feb 2023 7:30 AM GMTHyderabad: Natco Pharma Limited has announced the completion of a regulatory inspection from the United States Food and Drug Administration (USFDA)...
Patent Infringement case: Delhi HC rules in favour of Natco Pharma Ruchika Sharma6 Dec 2022 7:00 AM GMTNew Delhi: Natco Pharma has recently announced that the company has received a favourable verdict from Delhi High Court in a patent infringement...
Natco Pharma unveils first generic version of Pomalyst capsules in Australia Ruchika Sharma9 Nov 2022 10:31 AM GMTPomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.
Natco Pharma unveils Chlorantraniliprole (CTPR) formulated product NATGEN in India Ruchika Sharma26 Sep 2022 7:10 AM GMTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand...
Delhi HC nod to Natco Pharma for launch of Chlorantraniliprole and its formulations Ruchika Sharma20 Sep 2022 6:29 AM GMTCTPR technical is formulated into broadspectrum insecticides used across wide range of crops for pest management.
Natco Pharma secures USFDA nod for Trabectedin for Injection Ruchika Sharma18 Aug 2022 5:53 AM GMTHyderabad: Drugmaker, Natco Pharma Limited has recently announced that the U.S. Food and Drug Administration (USFDA) has granted tentative approval...
